Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0155339 (Brown)
 12,436 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Somatostatin (SS) was originally described as a growth hormone release inhibiting factor synthesised in the hypothalamus. Recently, SS and its receptor (SSTR) have been demonstrated in lymphoid tissues and seem to play a regulatory, largely inhibitory, role in immune responses. The aim of the present study was to check the immunosuppressive effect of a SS derived peptide, the octreotide (SMS 201-995) and to verify whether this molecule acted synergistically with FK506. An immunosuppressive effect of SMS was observed on the proliferation of rat spleen cells induced in vitro, either by polyclonal mitogens such as PHA or by alloantigens. With PHA stimulation, 10(-14) M SMS significantly enhanced the immunosuppressive action of 0.00001 microg/ml FK506. The addition of SMS in MLR (10(-11)-10(-9)M) increased the antiproliferative effect of both 0.0001 microg/ml and 0.00001 microg/ml FK506. In consideration of the extremely low concentration of both drugs that was required to obtain a good immunosuppression in vitro, we verified the association of FK506 and SMS in vivo in an allogeneic skin graft model that used Lewis (Lew) rats as donors and Brown Norway (BN) rats as recipients. BN treated with 0.1 mg/kg FK506 and 0.5-10 microg/kg SMS showed a significant increase in mean skin allograft survival time when compared to either a monotherapy or control group. None of the animals died or showed signs of drug-related toxicity. In conclusion, a combined therapy of SMS and FK506, administered at lower dosages than those that are considered therapeutic, led to an effective immunosuppression without any undesirable side effects.
 ...
PMID:Evidence that SMS 201-995 enhances the immunosuppressive effect of FK506. 981 92

The present study evaluated the effect of a brief mindfulness-based preventive intervention on (a) dispositional (MAAS; Brown & Ryan, 2003) and state (SMS; Tanay & Bernstein, 2010) mindfulness; (b) putative proximal factors/processes engendered through the development of mindfulness, including increased decentering (EQ-D; Fresco et al., 2007) and reduced experiential avoidance (AAQ; Hayes et al., 2004); and (c) distal mood and anxiety vulnerability factors, including reduced depression-related dysfunctional attitudes, (DAS; de Graaf, Roelofs, & Huibers, 2009), anxiety sensitivity (ASI-3; Taylor et al., 2007), and negative affectivity (PANAS-NA; Watson, Clark, & Tellegen, 1988) among a university-community sample in Israel. Fifty-three adult participants between the ages of 20 and 52 (M(age)=25.2 years, SD(age)=4.3 years; 65.4% women) were recruited from the Haifa University community. Nineteen participants were randomly assigned to an experimental condition (M(age)=25.3 years, SD(age)=4.3 years; 66% women) and studied prospectively over the course of a four-session (21-day) mindfulness skills training intervention; and 34 participants were randomly assigned to a no-intervention (control) condition (M(age)=24.9 years, SD(age)=2.4years; 64.7% women) and studied prospectively. Findings demonstrate statistically robust and clinically significant relations between mindfulness and the theorized proximal and distal mood and anxiety vulnerability factors. Findings are discussed with respect to their theoretical implications for better understanding mindfulness-psychopathology vulnerability relations, clinical implications for larger-scale universal and selective transdiagnostic prevention efforts, and future directions for this area of research.
 ...
PMID:Salutary proximal processes and distal mood and anxiety vulnerability outcomes of mindfulness training: a pilot preventive intervention. 2269 39

Accurate assessment of obsessions and compulsions is a crucial step in treatment planning for Obsessive-Compulsive Disorder (OCD). In this clinical case study, we sought to determine if the use of Ecological Momentary Assessment (EMA) could provide additional symptom information beyond that captured during standard assessment of OCD. We studied three adults diagnosed with OCD and compared the number and types of obsessions and compulsions captured using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) compared to EMA. Following completion of the Y-BOCS interview, participants then recorded their OCD symptoms into a digital voice recorder across a 12-h period in reply to randomly sent mobile phone SMS prompts. The EMA approach yielded a lower number of symptoms of obsessions and compulsions than the Y-BOCS but produced additional types of obsessions and compulsions not previously identified by the Y-BOCS. We conclude that the EMA-OCD procedure may represent a worthy addition to the suite of assessment tools used when working with clients who have OCD. Further research with larger samples is required to strengthen this conclusion.
...
PMID:A clinical case study of the use of ecological momentary assessment in obsessive compulsive disorder. 2486 May 21